• Mashup Score: 2
    Home - 2 year(s) ago

    This year we’re leaving screens behind and meeting in person. The Acute Leukemia Forum (ALF) is more than a conference–it’s a community we’ve been building for more than 25 years. For 2023, joining together again is an opportunity to enhance the live experience and build on our tradition of provocative ideas, challenging the status quo, and robust discussion. Of course, our renowned faculty…

    Source: events.medscapelive.org
    Categories: Dermatology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MedscapeLIVE
      MedscapeLIVE

      Grab your seat 🪑, amazing sessions with renowned faculty @DrPinkalDesai @LIsenalumhe_MD @CKadoch @BldCancerDoc @GuidoMarcucci06 @LoriMuffly @pietras_eric @aditishasMD @AbhaySinghMD @TheDoctorIsVin @ZhuoerXie @Dr_AmerZeidan @rosslevinemd https://t.co/6euXKFm45x #ALFlive23 https://t.co/b0c5Dz3x1w

  • Mashup Score: 1
    What Strategies Are Used to Treat Relapsed AML? - 2 year(s) ago

    Experts Dr. Pinkal Desai and Dr. Tapan Kadia discuss the heterogeneity of AML, how mutational status can change and why to have additional genomic testing after relapse.

    Source: Patient Power
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of PatientPower
      PatientPower

      What Strategies Are Used to Treat Relapsed Acute Myeloid Leukemia? Experts, @DrPinkalDesai from @WeillCornell & @TapKadia from @MDAndersonNews discuss the value of genomic profiling after relapse to help determine next steps in care: https://t.co/JeECyJkyom #leusm #aml

  • Mashup Score: 0
    What Strategies Are Used to Treat Relapsed AML? - 3 year(s) ago

    Experts Dr. Pinkal Desai and Dr. Tapan Kadia discuss the heterogeneity of AML, how mutational status can change and why to have additional genomic testing after relapse.

    Source: Patient Power
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of PatientPower
      PatientPower

      What Strategies Are Used to Treat Relapsed #AML? Experts, @DrPinkalDesai from @WeillCornell & @TapKadia from @MDAndersonNews discuss the value of genomic profiling after relapse to help determine next steps in care: https://t.co/GZMo7fr7Jc #leusm

  • Mashup Score: 4
    What Strategies Are Used to Treat Relapsed AML? - 3 year(s) ago

    Experts Dr. Pinkal Desai and Dr. Tapan Kadia discuss the heterogeneity of AML, how mutational status can change and why to have additional genomic testing after relapse.

    Source: Patient Power
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of PatientPower
      PatientPower

      What Strategies Are Used to Treat Relapsed #AML? Experts, @DrPinkalDesai from @WeillCornell & @TapKadia from @MDAndersonNews discuss the value of genomic profiling after relapse to help determine next steps in care: https://t.co/JeECyJkyom #leusm

  • Mashup Score: 0
    Active Disease, ICU Deferral Linked With COVID-19–Related Mortality in AML, ALL, and MDS - 3 year(s) ago

    Mortality rates in patients with acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndrome who were diagnosed with COVID-19 were higher compared with non-cancer populations who were infected with the virus.

    Source: OncLive
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of OncLive
      OncLive

      The findings, which were presented during the 2021 ASH Annual Meeting, indicated that patients with both active disease and neutropenia at diagnosis were more likely to experience severe COVID-19 infection. @DrPinkalDesai #ASH21 https://t.co/Zisaw91E0w https://t.co/eTFTeMqfMn

  • Mashup Score: 0
    Active Disease, ICU Deferral Linked With COVID-19–Related Mortality in AML, ALL, and MDS - 3 year(s) ago

    Mortality rates in patients with acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndrome who were diagnosed with COVID-19 were higher compared with non-cancer populations who were infected with the virus.

    Source: OncLive
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of OncLive
      OncLive

      Mortality rates in patients with acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndrome who were diagnosed with COVID-19 were higher compared with non-cancer populations who were infected with the virus. @DrPinkalDesai #ASH21 https://t.co/a6xmnlx8G8

  • Mashup Score: 0
    COVID-19 more severe in patients with active acute leukemia, myelodysplastic syndrome - 3 year(s) ago

    Patients with acute leukemia or myelodysplastic syndrome in an active state experienced significantly greater COVID-19 severity but not higher mortality due to the virus, according to research presented at ASH Annual Meeting and Exposition.The findings from the ASH Research Collaborative COVID-19 Registry for Hematology also showed patients with acute myeloid leukemia, acute lymphocytic leukemia

    Source: www.healio.com
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of GoHealio
      GoHealio

      🎙“Patients with active [acute leukemia or myelodysplastic syndrome] at the time of #COVID19 infection are at risk for severe COVID-19, requiring ICU admission, and should be monitored carefully,” says @DrPinkalDesai of @WeillCornell @nyphospital https://t.co/8h9txl009i #ASH21 https://t.co/Pe2ShiYLGq

  • Mashup Score: 2
    COVID-19 more severe in patients with active acute leukemia, myelodysplastic syndrome - 3 year(s) ago

    Patients with acute leukemia or myelodysplastic syndrome in an active state experienced significantly greater COVID-19 severity but not higher mortality due to the virus, according to research presented at ASH Annual Meeting and Exposition.The findings from the ASH Research Collaborative COVID-19 Registry for Hematology also showed patients with acute myeloid leukemia, acute lymphocytic leukemia

    Source: www.healio.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HemOncToday
      HemOncToday

      🎙“Patients with active [acute leukemia or myelodysplastic syndrome] at the time of #COVID19 infection are at risk for severe COVID-19, requiring ICU admission, and should be monitored carefully,” says @DrPinkalDesai of @WeillCornell @nyphospital https://t.co/f91o3mPJsO #ASH21 https://t.co/yzWHH316lF

Load More